Center In The News
Here you’ll find news about our physicians and other members of our team. Look to the side navigation for more information about events, seminars, workshops, videos and other public appearances.
The Center for Advanced Reproductive Services is pleased to congratulate Dr. Claudio Benadiva on his promotion to Full Professor in the Clinician Scholar category of the UConn School of Medicine and are proud to have him as part of our team. Read more here.
The Center for Advanced Reproductive Services Names Paul Verrastro Chief Executive Officer. He previously held the position of Chief Operating Officer and has been with the Center since 2000. Read more here.
Congratulations to both Dr. John Nulsen and Dr. Claudio Benadiva from the Center on their selection as one of America’s “Best Doctors” for 2016-2017. The Best Doctors in America List includes the nation’s most respected specialists and are the doctors that other doctors recognize as the best in their field.
Alison Bartolucci Appointed As Instructor at UCONN School of Medicine. It is with great pride that we announce Alison Bartolucci, the Center’s Operational Lab Director, has been granted a faculty appointment as an Instructor within the Department of Obstetrics & Gynecology at the UCONN School of Medicine.
Farmington Chamber of Commerce Awards the Center for Advanced Reproductive Services as Distinguished Business of the Year. This year’s Distinguished Business of the Year Award will be presented to The Center for Advanced Reproductive Services. Paul Verrastro, Chief Operating Officer of the Center, stated: “I can’t imagine a more meaningful contribution to a community than to help build its families. This award truly honors our patients who inspire us on a daily basis to be the type of organization worthy of such recognition.”
According to Cindy Scoville, Executive Director of the Farmington Chamber of Commerce and President and CEO of the Central CT Chambers of Commerce, the Distinguished Business of the Year Award is given to businesses that have made a substantial contribution to the community, have employees who individually and collectively participate in the community, and the physical presence of the business adds to the economic vitality and livability of our community.
Alison Bartolucci, Operational Lab Director, Presenting at 2016 Embryologists Summit. This year’s Clinical Embryologist Summit Conference will focus on discussion of developing and executing an effective quality management system. Alison Bartolucci will presenting a new concept, the QA dashboard. The QA dashboard is where participating labs share their quality control metrics online, thereby providing real time feedback in large numbers. By codifying this information in an online dashboard, the hope is for improved outcomes and better monitored performance across all participating labs.
The New England Fertility Society Awards Alison Bartolucci with Research Grant. The Center’s Operational Lab Director, Alison Bartolucci, received one of two eIVF Research Grants awarded by the New England Fertility Society. The grant is to perform a retrospective version of her uninterrupted culture project entitled “Pregnancy Outcome after Single Blastocyst Transfer” using the eIVF database, a database of de-identified information from 30,000 ART cycles from multiple IVF clinics. The purpose of this project is to study the early embryo morphology data on a large population of single blastocyst embryo transfers in order to determine if static morphology from day 2 and day 3 of development effect live birth rate after controlling for blastocyst quality.
The Center is Participating in New Personalized Reproductive Medicine Initiative. The Center is pleased to announce our participation in a Personalized Reproductive Medicine Initiative to decode fertility potential. We are partners in an alliance created to investigate what an individual’s genetic signature and personalized metrics say about his or her overall fertility. These insights have the potential to revolutionize how fertility difficulties are diagnosed, treated, and possibly prevented.
According to Piraye Yurttas Beim, Ph.D., Founder and Chief Executive Officer of Celmatix Inc., “the goal of the initiative is to drive innovation and collaboration, thereby accelerating the development and adoption of personalized medicine in the field of reproduction. We’ve all witnessed the profound impact that personalized medicine has had in other areas of medicine such as oncology. By implementing personalized medicine, these physicians have experienced a drastic shift in treatment strategies resulting in significantly higher survival rates for patients. We recognize the crucial need to accelerate a similar development and adoption of personalization in reproductive medicine. However, we know this can only be accomplished by us working collaboratively, representing the top public and private health institutions in the reproductive health field.”
Dr. Engmann Invited To Lecture. Dr. Lawrence Engmann will be conducting two lectures this fall. He will be attending the 7th world Congress on Ovulation induction in Bologna, Italy from September 3rd – 5th. His topic will be “Dual triggering with GnRHa and hCG.”
In October (1st-4th), he will be traveling to Halifax, Canada to present at the Canadian Fertility and Andrology Society Annual Meeting. His topic will be “Endometrial receptivity with agonist trigger.”
Dr. Nulsen and Dr. Benadiva Selected for Best Doctors in America 2015-2016. Both Dr. Nulsen and Dr. Benadiva have been selected for inclusion in the Best Doctors in America® 2015-2016 database based on the result of an extensive, confidential peer-review process. The Best Doctors list is being excerpted in the September 2015 issue of Hartford Magazine.
Recently published in the April issue of Fertility and Sterility
A review article by Peter Humaidan, M.D., Lawrence Engmann, M.D.and Claudio Benadiva, M.D entitled “Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches.”
Dr. Nulsen and Dr. Benadiva Named Top Docs by Hartford Magazine
The magazine recently announced its annual “Greater Hartford’s Best Doctors” list and once again, both Dr. John Nulsen and Dr. Claudio Benadiva made the list. The Top Docs list is compiled and maintained by Best Doctors Inc. The Best Doctors in America database includes approximately 53,000 doctors in more than 450 medical specialties and subspecialties worldwide. Best Doctors are:
- Reviewed and elected by their peers
- Clinically and academically accomplished
- Affiliated with national and global centers of excellence
- Leading medical practitioners, researchers and teachers
- Members of a prestigious, peer-reviewed group that includes the top 5% of U.S. physicians
COO Paul Verrastro speaks at annual American Society of Reproductive Medicine (ASRM) meeting
Paul Verrastro, MPA, Chief Operating Officer of the Center was an invited symposia speaker at the ASRM annual meeting in Honolulu, Hawaii. His topic was “Strategic Planning and Implementation.”
Dr. Lawrence Engmann has been selected as a guest speaker at the ESHRE
(European Society of Human Reproduction and Embryology) campus in Greece, October 31-November 1, 2014. ESHRE is the world’s leading society in reproductive science and medicine. The symposium is entitled “Rendering OHSS a complication from the past: state-of-the-art use of GnRH agonist triggering.”
What to Expect and How to Manage an IVF Cycle
Dr. Engmann will be addressing these topics in a workshop at Resolve of New England’s 20th Annual Fertility Treatment, Donor Choices and Adoption Conference, November 2, 2013, in Marlborough, MA. This workshop walks you through navigating an IVF cycle, including both the typical process and how to manage the unexpected.
Alison Finn Bartolucci, Operational Lab Director, named Embryologist of the Month of June 2013
In addition to the Embryologist of the Month of June 2013 honor, Alison and Linda Siano have been invited to give two talks at this year’s ASRM meeting. The first talk will cover sperm cryopreservation: different ways of preparing the sperm for cryopreservation, different protocols for freezing, and new techniques being implemented to freeze sperm from men with extremely low sperm counts. Their second talk is on embryo cryopreservation: methods of grading embryos and the importance of implementing a scoring system to reduce subjectivity, the significance of freezing embryos at different stages of development, different methods of freezing embryos and how to train embryologists on new freezing techniques.
Paper Selected For Publication in the Journal of the Connecticut State Medical Society
Dr. Claudio Benadiva, Linda Siano, as well as Dr. Engmann and Dr. Nulsen, recently completed a study comparing fertilization and embryo development between fresh and vitrified sibling occytes. Published in the April 2013 Journal of the Connecticut State Medical Society, this study provides a model to quickly assess the efficacy of a newly established egg vitrification program following ASRM guidelines in an investigational protocol.
Dr. Claudio Benadiva Named “Best Doctor” for 2013
Dr. Benadiva has been named a “Best Doctor,” becoming a member of a prestigious, peer-reviewed group that includes the top 5% of U.S. physicians. “Best Doctors,” reviewed and elected by their peers, are both clinically and academically accomplished and are affiliated with national and global centers of excellence.
American Society for Reproductive Medicine
Drs. Claudio Benadiva, Lawrence Engmann and John Nulsen were involved in content development and review for an ASRM credited course entitled “Ovarian Stimulation for IVF.” The purpose of this course is to provide continuing medical education for physicians.
Florida Society of Reproductive Endocrinology and Infertility
Dr. Benadiva was a featured speaker at this conference targeted to obstetricians, gynecologists, embryologists and nurses who have a specialized interest in the field of endocrinology and infertility. His topics included “Current Evidence of Agonist Triggers,” and “Practical Considerations with Lupron Triggers: Dosing of Medications, Monitoring, Etc.”